Balloon Catheter vs. Basket Catheter in Pancreatic Duct Stone Clearance

Sponsor
Changhai Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT05888012
Collaborator
(none)
6,493
1
134.2
48.4

Study Details

Study Description

Brief Summary

The aim of the study is to compare the safety and efficacy of the basket catheter with that of the balloon catheter for endoscopic extraction of pancreatic stones.

Condition or Disease Intervention/Treatment Phase
  • Device: basket catheter
  • Device: balloon catheter

Detailed Description

This is a retrospective cohort study. Patients with chronic pancreatitis who underwent ERCP for pancreatic duct stone extraction using either a basket or a balloon catheter were enrolled in this study.

Study Design

Study Type:
Observational
Actual Enrollment :
6493 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Efficacy and Safety Comparison of Balloon Catheter and Basket Catheter for Endoscopic Pancreatic Duct Stone Clearance
Actual Study Start Date :
Feb 1, 2012
Actual Primary Completion Date :
Dec 31, 2021
Actual Study Completion Date :
Apr 10, 2023

Outcome Measures

Primary Outcome Measures

  1. the rate of stone clearance in basket and balloon catheter groups [1 year after ERCP]

    complete clearance, defined as fragmentation of the pancreatic stones to < 3 mm and clearance of more than 90% of the fragments; partial clearance, defined as clearance of 50-90% of the fragments; and unsuccessful clearance, defined as the presence of pancreatic stones ≥ 3 mm or clearance of less than 50% of the fragments.

Secondary Outcome Measures

  1. the rates of ERCP peri-procedural outcomes and the rates of complications of ERCP in basket and balloon catheter groups [1 year after ERCP]

    ERCP peri-procedural outcomes included difficult cannulation, endoscopic sphincterotomy, dilation of stenosis, and extraction through the minor papilla. Major post-ERCP complications, which were defined according to the Consensus Criteria, included post-ERCP pancreatitis (PEP), bleeding, infection, perforation, and basket impaction

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • CP patients with main pancreatic duct (MPD) stones who underwent ERCP
Exclusion Criteria:
  • Patients had undergone pancreatic surgery or gastrectomy with Billroth II reconstruction prior to the ERCP procedure

  • Patients were suspected of having a malignant tumor

  • Patients combined with bile duct stones

  • Patients had severe pancreatic duct structure

  • Patients with insufficient clinical data

  • Patients with previous ERCP treatment

  • Patients had received both catheters

Contacts and Locations

Locations

Site City State Country Postal Code
1 Changhai Hospital Shanghai Shanghai China 200433

Sponsors and Collaborators

  • Changhai Hospital

Investigators

  • Principal Investigator: Zhuan Liao, Changhai Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Zhuan Liao, Principal Investigator, Changhai Hospital
ClinicalTrials.gov Identifier:
NCT05888012
Other Study ID Numbers:
  • Basket vs. Balloon
First Posted:
Jun 5, 2023
Last Update Posted:
Jun 5, 2023
Last Verified:
May 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
Yes
Keywords provided by Zhuan Liao, Principal Investigator, Changhai Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 5, 2023